Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (BPT) – Do you find it difficult to swallow food? Does food feel ...

This is a video synopsis/summary of an Insights involving Elizabeth Spencer, MD. Spencer explained the complexities of eosinophilic esophagitis (EoE). EoE, an allergic inflammatory condition of the ...

“In EoE, PPIs are used for anti-inflammatory properties rather than acid suppression,” says Alex Koral, MD, a gastroenterologist and an associate professor of pediatric gastroenterology at Yale School ...

Elizabeth Spencer, MD, discusses various treatments for eosinophilic esophagitis (EoE) across age groups, highlighting the role of dietary modifications, proton pump inhibitors, swallowed ...

Eosinophilic esophagitis causes chronic inflammation in the esophagus, which can make it difficult for a person to eat, drink, or even swallow saliva. A person may also experience related symptoms, ...

Pediatric patient self-reported and parent proxy-reported outcomes are critical components of evaluating the impact of current and planned treatments for pediatric EoE. We report a patient self-report ...

Navigating everyday life with eosinophilic esophagitis (EoE) can come with challenges, and those can be magnified when you’re traveling. Figuring out which foods are safe to eat, being far from your ...

The long-term outcome of EoE is still unclear; symptoms frequently subside and then recur when treatment is stopped. 9 Some evidence in adults suggests that EoE may progress to a fibrostenotic stage ...

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in patients with eosinophilic esophagitis at 24 weeks, a randomized phase III ...

Please provide your email address to receive an email when new articles are posted on . The most common symptom of EoE before pregnancy was dysphagia, followed by reflux and pain. Half of the patients ...

Celldex Therapeutics (NASDAQ:CLDX) slipped in premarket trading on Wednesday after releasing results from its Phase 2 study of Barzolvolimab in patients with eosinophilic esophagitis (EoE), a chronic ...

Eosinophilic esophagitis (EoE) is no longer a rarity in European clinics. Diagnosed increasingly over the past three decades, EoE is commonly managed with pharmacotherapy, elimination diets, and, when ...